12/17
07:30 am
hbio
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
High
Report
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
12/13
07:50 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Zacks Research to a "hold" rating.
11/27
02:48 pm
hbio
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
01:59 pm
hbio
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
01:27 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
Medium
Report
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
11/17
01:27 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
Medium
Report
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at
Wall Street
11/9
08:55 am
hbio
Analysts Have Been Trimming Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Price Target After Its Latest Report [Yahoo! Finance]
High
Report
Analysts Have Been Trimming Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Price Target After Its Latest Report [Yahoo! Finance]
11/9
01:13 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was downgraded by analysts at
Wall Stre
High
Report
Harvard Bioscience (NASDAQ:HBIO) was downgraded by analysts at
Wall Stre
11/7
07:07 pm
hbio
Is It Time To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? [Yahoo! Finance]
High
Report
Is It Time To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? [Yahoo! Finance]
11/7
02:18 am
hbio
Harvard Bioscience targets $22.5M–$24.5M Q4 revenue as backlog reaches two-year high, expanding product rollouts and distribution [Seeking Alpha]
Medium
Report
Harvard Bioscience targets $22.5M–$24.5M Q4 revenue as backlog reaches two-year high, expanding product rollouts and distribution [Seeking Alpha]
11/6
07:00 am
hbio
Harvard Bioscience Announces Third Quarter 2025 Financial Results
High
Report
Harvard Bioscience Announces Third Quarter 2025 Financial Results
10/30
08:00 am
hbio
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
Medium
Report
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET